HARPdoc Trial: Implementation Analysis for Diabetes Hypoglycemia Programs

A hybrid randomized clinical trial conducted in the United Kingdom and United States between July 2018 and December 2019. The dataset contains implementation and clinical outcome data from the HARPdoc trial, comparing a novel psychoeducation program to an existing one for adults with type 1 diabetes and problematic hypoglycemia. It was authored by Tayana Soukup and shared under a CC-BY-4.0 license.

Use Cases

• Compare perceived acceptability, feasibility, and appropriateness of two clinical interventions based on survey data from participants and professionals.
• Analyze associations between implementation outcomes (acceptability, appropriateness, feasibility) and clinical outcomes like diabetes distress, anxiety, and depression.
• Investigate potential mediation effects of implementation outcomes on cognitive and mental health improvements in a clinical trial setting.

Strengths

• Data is from a hybrid randomized clinical trial with a defined timeframe (July 2018 to December 2019).
• Implementation outcomes were measured using published validated surveys.
• Clinical outcomes, including anxiety and depression, were measured using validated self-reported questionnaires.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The primary data file is a 506.7 KB DOCX document, suggesting a small-scale, likely summary-level dataset rather than raw participant records.

Provenance

Source

figshare

Collection Method

Data collected as part of the HARPdoc hybrid randomized clinical trial.

Time Range

July 2018 to December 2019

Freshness

Last updated 2026-05-19 05:38:17; freshness should be verified.

Geography

United Kingdom and United States